{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-08-27",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 19
    }
  },
  "results": [
    {
      "update_type": "Reverified",
      "initial_posting_date": "02/08/2019",
      "package_ndc": "67457-421-30",
      "generic_name": "Dexamethasone Sodium Phosphate Injection",
      "contact_info": "800-796-9526",
      "availability": "Available",
      "openfda": {
        "application_number": [
          "ANDA040803"
        ],
        "brand_name": [
          "DEXAMETHASONE SODIUM PHOSPHATE"
        ],
        "generic_name": [
          "DEXAMETHASONE SODIUM PHOSPHATE"
        ],
        "manufacturer_name": [
          "Mylan Institutional LLC"
        ],
        "product_ndc": [
          "67457-421",
          "67457-423",
          "67457-422",
          "67457-420"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "INTRA-ARTICULAR",
          "INTRALESIONAL",
          "INTRAMUSCULAR",
          "INTRAVENOUS",
          "SOFT TISSUE"
        ],
        "substance_name": [
          "DEXAMETHASONE SODIUM PHOSPHATE"
        ],
        "rxcui": [
          "309696",
          "1116927",
          "1812194"
        ],
        "spl_id": [
          "dd5c82b6-a194-462c-9626-34a9b410cfea"
        ],
        "spl_set_id": [
          "dff598e8-e662-411f-978d-4ba3fb8ef7db"
        ],
        "package_ndc": [
          "67457-423-00",
          "67457-423-12",
          "67457-422-00",
          "67457-422-54",
          "67457-421-00",
          "67457-421-30",
          "67457-420-00",
          "67457-420-10"
        ],
        "unii": [
          "AI9376Y64P"
        ]
      },
      "update_date": "08/20/2026",
      "therapeutic_category": [
        "Dermatology",
        "Endocrinology/Metabolism",
        "Gastroenterology",
        "Hematology",
        "Neurology",
        "Oncology",
        "Ophthalmology",
        "Other",
        "Pulmonary/Allergy",
        "Rheumatology"
      ],
      "dosage_form": "Injection",
      "presentation": "Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 67457-421-30)",
      "company_name": "Mylan Institutional, a Viatris Company",
      "status": "Current"
    }
  ]
}